Characterization of ANXA1 in chemotherapy resistance of head and neck squamous cell carcinoma: insights from artificial intelligence and integrative bioinformatics analysis

Our study highlighted the CR in risk stratification for HNSCC patients and ANXA1 in the pathogenesis of HNSCC, which can guide personalized and precision medicine for HNSCC patients.